http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2008145789-A1
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_371cd250c00fa9dd986c9d016a14a821 http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_bd2490e6643d2535d7de320fa40dce9a http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_1023880af10dbe26a57dfb1cb687f92d http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_640588cacab62bd4db7d9b70f861b417 http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_f138b88c2017db53edf7b648ec0d3ce6 |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-506 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-28 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P25-28 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-506 |
| filingDate | 2008-05-28-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_23acb71420a61b88e87f7b5da6a5570d http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_eb3b9139e80fa372118c74c077d233da http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_307e95b5660b5ce02f154b016ae35880 |
| publicationDate | 2008-12-04-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | WO-2008145789-A1 |
| titleOfInvention | Use of compounds derived from benzamidine methanesulphonate or a pharmaceutically acceptable salt thereof, for example imatinib mesylate, for the preparation of a drug for the treatment of neurodegenerative niemann-pick c disease (npc) |
| abstract | The invention relates to the use of imatinib mesylate for the treatment of metabolic disorders characterised by neurodegeneration, in particular a metabolic disorder characterised by an inability to metabolize lipids, such as in patients with Niemann-Pick C disease. More specifically, the invention relates to a treatment for neurodegenerative diseases, comprising the delivery of a therapeutically effective quantity of a compound derived from benzamidine methanesulphonate or a pharmaceutically acceptable salt thereof. The invention also relates to a treatment for neurodegenerative diseases, comprising the delivery of a therapeutically effective quantity of a compound derived from imatinib mesylate or a pharmaceutically acceptable salt thereof. |
| isCitedBy | http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2020210798-A1 |
| priorityDate | 2007-05-28-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 49.